Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo
- PMID: 11070161
- DOI: 10.1016/s1074-7613(00)00042-x
Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo
Abstract
The AML1:CBFbeta transcription factor complex is essential for definitive hematopoiesis. Null mutations in mouse AML1 result in midgestational lethality with a complete lack of fetal liver hematopoiesis. While the cell autonomous nature and expression pattern of AML1 suggest an intrinsic role for this transcription factor in the developing hematopoietic system, no direct link to a functional cell type has been made. Here, we examine the consequences of AML1 loss in hematopoietic stem cells (HSC) of the mouse embryo. We demonstrate an absolute requirement for AML1 in functional HSCs. Moreover, haploinsufficiency results in a dramatic change in the temporal and spatial distribution of HSCs, leading to their early appearance in the normal position in the aorta-gonad-mesonephros region and also in the yolk sac.
Similar articles
-
The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region.Dev Biol. 2000 Apr 1;220(1):27-36. doi: 10.1006/dbio.2000.9617. Dev Biol. 2000. PMID: 10720428
-
Development of hematopoietic stem cell activity in the mouse embryo.Immunity. 1994 Jul;1(4):291-301. doi: 10.1016/1074-7613(94)90081-7. Immunity. 1994. PMID: 7889417
-
Ontogeny and genetics of the hemato/lymphopoietic system.Curr Opin Immunol. 2002 Apr;14(2):186-91. doi: 10.1016/s0952-7915(02)00320-5. Curr Opin Immunol. 2002. PMID: 11869891 Review.
-
Mpl receptor defect leads to earlier appearance of hematopoietic cells/hematopoietic stem cells in the Aorta-Gonad-Mesonephros region, with increased apoptosis.Int J Dev Biol. 2010;54(6-7):1067-74. doi: 10.1387/ijdb.103104mf. Int J Dev Biol. 2010. PMID: 20711984
-
Role of hematopoietic stem cells in angiogenesis.Int J Hematol. 2001 Oct;74(3):266-71. doi: 10.1007/BF02982059. Int J Hematol. 2001. PMID: 11721961 Review.
Cited by
-
Runx1/AML1 in normal and abnormal hematopoiesis.Int J Hematol. 2005 Jul;82(1):1-8. doi: 10.1532/IJH97.05075. Int J Hematol. 2005. PMID: 16105753 Review.
-
Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.BMC Dev Biol. 2007 Jul 12;7:84. doi: 10.1186/1471-213X-7-84. BMC Dev Biol. 2007. PMID: 17626615 Free PMC article.
-
Novel methods for determining hematopoietic stem and progenitor cell emergence in the murine yolk sac.Int J Dev Biol. 2010;54(6-7):1003-9. doi: 10.1387/ijdb.103118cl. Int J Dev Biol. 2010. PMID: 20711978 Free PMC article. Review.
-
Genetic evidence of PEBP2beta-independent activation of Runx1 in the murine embryo.Int J Hematol. 2008 Sep;88(2):134-138. doi: 10.1007/s12185-008-0121-4. Epub 2008 Jul 2. Int J Hematol. 2008. PMID: 18594778
-
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells.Leuk Lymphoma. 2018 Sep;59(9):2188-2200. doi: 10.1080/10428194.2017.1410882. Epub 2017 Dec 18. Leuk Lymphoma. 2018. PMID: 29249175 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases